Table of Contents Table of Contents 2 List of Tables 5 List of Figures 6 Introduction 7 Global Markets Direct Report Coverage 7 Pertussis (Whooping Cough) Overview 8 Therapeutics Development 9 Pipeline Products for Pertussis (Whooping Cough) - Overview 9 Pipeline Products for Pertussis (Whooping Cough) - Comparative Analysis 10 Pertussis (Whooping Cough) - Therapeutics under Development by Companies 11 Pertussis (Whooping Cough) - Therapeutics under Investigation by Universities/Institutes 13 Pertussis (Whooping Cough) - Pipeline Products Glance 14 Late Stage Products 14 Clinical Stage Products 15 Early Stage Products 16 Pertussis (Whooping Cough) - Products under Development by Companies 17 Pertussis (Whooping Cough) - Products under Investigation by Universities/Institutes 19 Pertussis (Whooping Cough) - Companies Involved in Therapeutics Development 20 Beijing Minhai Biotechnology Co Ltd 20 Beijing Tiantan Biological Products Co Ltd 21 Bharat Biotech International Ltd 22 Biken Inc 23 Biological E Ltd 24 Boryung Pharmaceutical Co Ltd 25 Daiichi Sankyo Company Ltd 26 DBV Technologies SA 27 GlaxoSmithKline Plc 28 Green Cross Corp 29 ILiAD Biotechnologies LLC 30 Indian Immunologicals Ltd 31 Kaketsuken KK 32 LG Life Science LTD 33 NanoBio Corp 34 Panacea Biotec Ltd 35 Sanofi Pasteur SA 36 Serum Institute of India Ltd 37 Shantha Biotechnics Ltd 38 Synthetic Biologics Inc 39 Zydus Cadila Healthcare Ltd 40 Pertussis (Whooping Cough) - Therapeutics Assessment 41 Assessment by Monotherapy Products 41 Assessment by Combination Products 42 Assessment by Target 43 Assessment by Route of Administration 45 Assessment by Molecule Type 47 Drug Profiles 49 (diphtheria + Haemophilus influenza [serotype B] + hepatitis B + pertussis (wholl cell) + tetanus) (pentavalent) vaccine - Drug Profile 49 (diphtheria + Haemophilus influenza [serotype B] + pertussis (acellular) + polio + tetanus) vaccine - Drug Profile 50 (diphtheria + haemophilus influenza [serotype B] + pertussis (acellular) + tetanus) vaccine - Drug Profile 51 (diphtheria + Haemophilus influenzae [serotype B] + hepatitis B + meningococcal [serotype C] + pertussis (whole cell) + poliomyelitis + tetanus) (7-valent) vaccine - Drug Profile 52 (diphtheria + Haemophilus influenzae [serotype B] + hepatitis B + pertussis (whole cell) + polio + tetanus) (hexavalent) vaccine - Drug Profile 53 (diphtheria + haemophilus influenzae [serotype B] + hepatitis B + pertussis (whole cell) + poliomyelitis + tetanus) (hexavalent) vaccine - Drug Profile 54 (diphtheria + haemophilus influenzae [serotype B] + hepatitis B + pertussis (whole cell) + poliomyelitis + tetanus) (hexavalent) vaccine - Drug Profile 55 (diphtheria + Haemophilus influenzae [serotype B] + hepatitis B + pertussis (whole cell) + tetanus) (pentavalent) vaccine - Drug Profile 56 (diphtheria + haemophilus influenzae [serotype B] + hepatitis B + pertussis (whole cell) + tetanus) (pentavalent) vaccine - Drug Profile 57 (diphtheria + Haemophilus influenzae [serotype B] + pertussis (whole cell) + polio + tetanus)(pentavalent) vaccine - Drug Profile 58 (diphtheria + Haemophilus influenzae [serotype B] + pertussis (whole-cell) + tetanus) vaccine - Drug Profile 59 (diphtheria + haemophilus influenzae [serotype B] + pertussis + poliomyelitis + tetanus) vaccine - Drug Profile 60 (diphtheria + pertussis (acellular) + tetanus) vaccine - Drug Profile 61 (diphtheria + pertussis (acellular) + tetanus) vaccine - Drug Profile 62 (diphtheria + pertussis (acellular) + tetanus) vaccine - Drug Profile 63 (diphtheria + pertussis (acellular) + tetanus) vaccine - Drug Profile 64 (diphtheria + pertussis (acellular) + tetanus) vaccine - Drug Profile 65 (diphtheria + pertussis (acellular) + tetanus) vaccine 1 - Drug Profile 66 (diphtheria + pertussis (acellular) + tetanus) vaccine 2 - Drug Profile 67 (diphtheria + pertussis (whole cell) + tetanus) vaccine - Drug Profile 68 (diphtheria + pertussis (whole-cell) + tetanus) vaccine - Drug Profile 69 (diphtheria + tetanus + pertussis (acellular) + hepatitis B + poliomyelitis [serotypes Mahoney + MEF-1 + Saukett] + haemophilus influenza [serotype B]) vaccine - Drug Profile 70 (diphtheria + tetanus + pertussis (acellular) + poliomyelitis + haemophilus influenzae [serotype B]) vaccine - Drug Profile 72 (hepatitis B + pertussis) vaccine - Drug Profile 73 bladder cancer + pertussis + tuberculosis vaccine - Drug Profile 74 BVN-002 - Drug Profile 75 Eupenta - Drug Profile 76 GC-3111A - Drug Profile 77 KD-370 - Drug Profile 78 LBVD - Drug Profile 79 pertussis (acellular) vaccine - Drug Profile 80 pertussis (acellular) vaccine - Drug Profile 81 pertussis (whole cell) vaccine - Drug Profile 82 pertussis [strain BPZE1] vaccine - Drug Profile 83 pertussis vaccine - Drug Profile 85 pertussis vaccine - Drug Profile 86 pertussis vaccine - Drug Profile 87 SYN-005 - Drug Profile 89 VN-0103 - Drug Profile 91 VN-0105 - Drug Profile 92 Pertussis (Whooping Cough) - Dormant Projects 93 Pertussis (Whooping Cough) - Discontinued Products 95 Pertussis (Whooping Cough) - Product Development Milestones 96 Featured News & Press Releases 96 Appendix 107 Methodology 107 Coverage 107 Secondary Research 107 Primary Research 107 Expert Panel Validation 107 Contact Us 107 Disclaimer 108

List of Tables Number of Products under Development for Pertussis (Whooping Cough), H2 2016 12 Number of Products under Development for Pertussis (Whooping Cough) - Comparative Analysis, H2 2016 13 Number of Products under Development by Companies, H2 2016 15 Number of Products under Investigation by Universities/Institutes, H2 2016 16 Comparative Analysis by Late Stage Development, H2 2016 17 Comparative Analysis by Clinical Stage Development, H2 2016 18 Comparative Analysis by Early Stage Development, H2 2016 19 Products under Development by Companies, H2 2016 20 Products under Development by Companies, H2 2016 (Contd..1) 21 Products under Investigation by Universities/Institutes, H2 2016 22 Pertussis (Whooping Cough) - Pipeline by Beijing Minhai Biotechnology Co Ltd, H2 2016 23 Pertussis (Whooping Cough) - Pipeline by Beijing Tiantan Biological Products Co Ltd, H2 2016 24 Pertussis (Whooping Cough) - Pipeline by Bharat Biotech International Ltd, H2 2016 25 Pertussis (Whooping Cough) - Pipeline by Biken Inc, H2 2016 26 Pertussis (Whooping Cough) - Pipeline by Biological E Ltd, H2 2016 27 Pertussis (Whooping Cough) - Pipeline by Boryung Pharmaceutical Co Ltd, H2 2016 28 Pertussis (Whooping Cough) - Pipeline by Daiichi Sankyo Company Ltd, H2 2016 29 Pertussis (Whooping Cough) - Pipeline by DBV Technologies SA, H2 2016 30 Pertussis (Whooping Cough) - Pipeline by GlaxoSmithKline Plc, H2 2016 31 Pertussis (Whooping Cough) - Pipeline by Green Cross Corp, H2 2016 32 Pertussis (Whooping Cough) - Pipeline by ILiAD Biotechnologies LLC, H2 2016 33 Pertussis (Whooping Cough) - Pipeline by Indian Immunologicals Ltd, H2 2016 34 Pertussis (Whooping Cough) - Pipeline by Kaketsuken KK, H2 2016 35 Pertussis (Whooping Cough) - Pipeline by LG Life Science LTD, H2 2016 36 Pertussis (Whooping Cough) - Pipeline by NanoBio Corp, H2 2016 37 Pertussis (Whooping Cough) - Pipeline by Panacea Biotec Ltd, H2 2016 38 Pertussis (Whooping Cough) - Pipeline by Sanofi Pasteur SA, H2 2016 39 Pertussis (Whooping Cough) - Pipeline by Serum Institute of India Ltd, H2 2016 40 Pertussis (Whooping Cough) - Pipeline by Shantha Biotechnics Ltd, H2 2016 41 Pertussis (Whooping Cough) - Pipeline by Synthetic Biologics Inc, H2 2016 42 Pertussis (Whooping Cough) - Pipeline by Zydus Cadila Healthcare Ltd, H2 2016 43 Assessment by Monotherapy Products, H2 2016 44 Assessment by Combination Products, H2 2016 45 Number of Products by Stage and Target, H2 2016 47 Number of Products by Stage and Route of Administration, H2 2016 49 Number of Products by Stage and Molecule Type, H2 2016 51 Pertussis (Whooping Cough) - Dormant Projects, H2 2016 96 Pertussis (Whooping Cough) - Dormant Projects (Contd..1), H2 2016 97 Pertussis (Whooping Cough) - Discontinued Products, H2 2016 98 List of Figures Number of Products under Development for Pertussis (Whooping Cough), H2 2016 12 Number of Products under Development for Pertussis (Whooping Cough) - Comparative Analysis, H2 2016 13 Number of Products under Development by Companies, H2 2016 14 Number of Products under Investigation by Universities/Institutes, H2 2016 16 Comparative Analysis by Late Stage Development, H2 2016 17 Comparative Analysis by Clinical Stage Development, H2 2016 18 Comparative Analysis by Early Stage Products, H2 2016 19 Assessment by Monotherapy Products, H2 2016 44 Assessment by Combination Products, H2 2016 45 Number of Products by Targets, H2 2016 46 Number of Products by Stage and Targets, H2 2016 46 Number of Products by Routes of Administration, H2 2016 48 Number of Products by Stage and Routes of Administration, H2 2016 48 Number of Products by Molecule Types, H2 2016 50 Number of Products by Stage and Molecule Types, H2 2016 50

Beijing Minhai Biotechnology Co Ltd Beijing Tiantan Biological Products Co Ltd Bharat Biotech International Ltd Biken Inc Biological E Ltd Boryung Pharmaceutical Co Ltd Daiichi Sankyo Company Ltd DBV Technologies SA GlaxoSmithKline Plc Green Cross Corp ILiAD Biotechnologies LLC Indian Immunologicals Ltd Kaketsuken KK LG Life Science LTD NanoBio Corp Panacea Biotec Ltd Sanofi Pasteur SA Serum Institute of India Ltd Shantha Biotechnics Ltd Synthetic Biologics Inc Zydus Cadila Healthcare Ltd